BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2524605)

  • 1. Identification of Staphylococcus epidermidis vascular graft infections: a comparison of culture techniques.
    Bergamini TM; Bandyk DF; Govostis D; Vetsch R; Towne JB
    J Vasc Surg; 1989 May; 9(5):665-70. PubMed ID: 2524605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection of vascular prostheses caused by bacterial biofilms.
    Bergamini TM; Bandyk DF; Govostis D; Kaebnick HW; Towne JB
    J Vasc Surg; 1988 Jan; 7(1):21-30. PubMed ID: 2961893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface biofilm disruption. Enhanced recovery of microorganisms from vascular prostheses.
    Tollefson DF; Bandyk DF; Kaebnick HW; Seabrook GR; Towne JB
    Arch Surg; 1987 Jan; 122(1):38-43. PubMed ID: 3541853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of bacteria-biofilm graft infection by in situ replacement in normal and immune-deficient states.
    Bandyk DF; Kinney EV; Riefsnyder TI; Kelly H; Towne JB
    J Vasc Surg; 1993 Sep; 18(3):398-405; discussion 405-6. PubMed ID: 8104253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft.
    Goëau-Brissonnière O; Mercier F; Nicolas MH; Bacourt F; Coggia M; Lebrault C; Pechère JC
    J Vasc Surg; 1994 Apr; 19(4):739-41. PubMed ID: 8164289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural history of bacterial biofilm graft infection.
    Bergamini TM; Corpus RA; Brittian KR; Peyton JC; Cheadle WG
    J Surg Res; 1994 May; 56(5):393-6. PubMed ID: 8170137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular prosthetic infection with Staphylococcus epidermidis: experimental study of pathogenesis and therapy.
    Martin LF; Harris JM; Fehr DM; Peter AO; Appelbaum PC; Spangler SK; Thiele BL
    J Vasc Surg; 1989 Mar; 9(3):464-71. PubMed ID: 2921795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sonication provides maximal recovery of staphylococcus epidermidis from slime-coated vascular prosthetics.
    Wengrovitz M; Spangler S; Martin LF
    Am Surg; 1991 Mar; 57(3):161-4. PubMed ID: 1825907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
    Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
    Int Angiol; 1999 Sep; 18(3):225-32. PubMed ID: 10688422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of vascular graft infection by in situ replacement with cryopreserved aortic allografts: an experimental study.
    Knosalla C; Goëau-Brissonnière O; Leflon V; Bruneval P; Eugène M; Pechère JC; Koskas F; Nicolas MH; Leschi JP; Gerota J; Kieffer E
    J Vasc Surg; 1998 Apr; 27(4):689-98. PubMed ID: 9576083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microbiology of explanted vascular prostheses.
    Kaebnick HW; Bandyk DF; Bergamini TW; Towne JB
    Surgery; 1987 Oct; 102(4):756-62. PubMed ID: 3310303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anastomotic tensile strength following in situ replacement of an infected abdominal aortic graft.
    Vetsch R; Bandyk DF; Schmitt DD; Bergamini TM; Storey JD; Towne JB
    Arch Surg; 1989 Apr; 124(4):425-8. PubMed ID: 2522764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
    Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
    Int Angiol; 2000 Jun; 19(2):158-65. PubMed ID: 10905800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis against Staphylococcus epidermidis vascular graft infection with rifampicin-soaked, gelatin-sealed Dacron.
    Sardelic F; Ao PY; Taylor DA; Fletcher JP
    Cardiovasc Surg; 1996 Jun; 4(3):389-92. PubMed ID: 8782944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ replacement of vascular prostheses infected by bacterial biofilms.
    Bandyk DF; Bergamini TM; Kinney EV; Seabrook GR; Towne JB
    J Vasc Surg; 1991 May; 13(5):575-83. PubMed ID: 2027196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of a triple antimicrobial-bonded Dacron graft for the prevention of aortic graft infection.
    Aboshady I; Raad I; Shah AS; Vela D; Dvorak T; Safi HJ; Buja LM; Khalil KG
    J Vasc Surg; 2012 Sep; 56(3):794-801. PubMed ID: 22579134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of perioperative vascular prosthetic infection with a novel triple antimicrobial-bonded arterial graft.
    Aboshady I; Raad I; Vela D; Hassan M; Aboshady Y; Safi HJ; Buja LM; Khalil KG
    J Vasc Surg; 2016 Dec; 64(6):1805-1814. PubMed ID: 26626182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local application of vancomycin for prophylaxis of graft infection: release of vancomycin from antibiotic-bonded Dacron grafts, toxicity in endothelial cell culture, and efficacy against graft infection in an animal model.
    Muhl E; Gatermann S; Iven H; Dendorfer A; Bruch HP
    Ann Vasc Surg; 1996 May; 10(3):244-53. PubMed ID: 8792993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of a gram-negative and a gram-positive infection on autogenous and prosthetic grafts.
    Geary KJ; Tomkiewicz ZM; Harrison HN; Fiore WM; Geary JE; Green RM; DeWeese JA; Ouriel K
    J Vasc Surg; 1990 Feb; 11(2):339-45; discussion 346-7. PubMed ID: 2105400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic antibiotics prevent bacterial biofilm graft infection.
    Bergamini TM; Peyton JC; Cheadle WG
    J Surg Res; 1992 Feb; 52(2):101-5. PubMed ID: 1346815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.